Premium
Examining the role of diabetes mellitus in ST‐elevation myocardial infarction
Author(s) -
Chandiramani Rishi,
Mehran Roxana
Publication year - 2019
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28605
Subject(s) - medicine , conventional pci , cardiology , myocardial infarction , diabetes mellitus , revascularization , clinical endpoint , st elevation , clinical trial , endocrinology
Key Points Except for a reduction in the rate of repeat revascularization, there was no benefit of EES over BMS in 1‐year and 5‐year clinical outcomes for diabetic patients with STEMI. In nondiabetic patients, a beneficial effect of using EES was observed in most clinical endpoints at 5 years. Overall, diabetic patients were associated with significantly worse long‐term outcomes following PCI for STEMI compared to nondiabetics.